NEW YORK--(BUSINESS WIRE)--May 9, 2006--INNOVIVE Pharmaceuticals Inc., a Manhattan-based biopharmaceutical company, announced today that Neil Herskowitz has been appointed to its board of directors. "We welcome Neil Herskowitz as a director and look forward to the guidance that will come from his wealth of knowledge and experience," said Steven Kelly, president and CEO, INNOVIVE Pharmaceuticals Inc.
